Shi-Yi Wang on Shifting End-of-Life Treatment Paradigms

August 2, 2016
Shi-Yi Wang, MD, PhD

Shi-Yi Wang, MD, PhD, assistant professor of Epidemiology at Yale School of Public Health, discusses the need for change in aggressive end-of-life cancer treatment.

Shi-Yi Wang, MD, PhD, assistant professor of Epidemiology at Yale School of Public Health, discusses the need for change in aggressive end-of-life cancer treatment.

In a study that analyzed Medicare data, Wang found that early hospice enrollment can potentially decrease end-of-life expenditures, but only when the expenditures are higher to begin with. Wang says that aggressive end-of-life care is the current norm, so doctors typically follow suit, regardless of whether or not the care is warranted. He is hoping that this research will motivate leaders in the field to carefully consider the cost and effectiveness of hospice and end-of-life care and make decisions accordingly.